Company / Current Liabilities per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$12.03
FY2025
5-year range
$10.11 / $12.03
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#16 of 210
Health Care
What the data says
Among 210 Health Care companies, TEVA PHARMACEUTICAL INDUSTRIES LTD is in the bottom 8% for current liabilities per share. Current Liabilities per Share has increased for 4 consecutive years, from $10.11 in FY2021 to $12.03 in FY2025.
Based on SEC 10-K filings.
12.03 in FY2025 with a 5-year CAGR of -1.4%. Top quartile in the Health Care sector.
Increased from $11.06 to $12.03 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Sector benchmark
-23.8% below sector average
Key checks
Key Insights
- TEVA PHARMACEUTICAL INDUSTRIES LTD's current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 4.3% year-over-year.
- Ranks #16 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.03 | +4.3% |
| FY2024 | $11.53 | +4.2% |
| FY2023 | $11.06 | +5.6% |
| FY2022 | $10.47 | +3.6% |
| FY2021 | $10.11 | -21.6% |
| FY2020 | $12.89 | -4.2% |
| FY2019 | $13.46 | -100.0% |
| FY2018 | $14903225.81 | +84491152.8% |
| FY2017 | $17.64 | -100.0% |
| FY2016 | $19238293.44 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026